Pharmaceutical intermediates

Revumenib Intermediates

12 pharmaceutical intermediates for Revumenib. Indication: Leukemia.

About Revumenib

12 intermediates currently listed for Revumenib. Request specifications, documentation or a quotation for any item below.

Revumenib intermediates
Product Name	CAS No.	Molecular Formula	Physical Properties
2-((4-(2,7-diazaspiro[3.5]nonan-2-yl)pyrimidin-5-yl)oxy)-N-ethyl-5-fluoro-N-isopropylbenzamide	2169920-03-8	/	/
4-methylbenzene-1-sulfonic acid [trans-4-ethylsulfonylaminocyclohexyl] methyl ester	2169920-33-4	/	/
N-[trans-4-(hydroxymethyl)cyclohexyl]ethane-1-sulfonamide	2169920-32-3	/	/
methyl trans-4-aminocyclohexanecarboxylate hydrochloride	61367-07-5	/	/
tert-butyl 2-(5-(2-(ethyl(isopropyl)carbamoyl)-4-fluorophenoxy)pyrimidin-4-yl)-2,7-diazaspiro[3.5]nonane-7-carboxylate	2169922-99-8	/	/
tert-butyl 2,7-diazaspiro[3.5]nonane-7-carboxylate	896464-16-7	/	/
2-((4-chloropyrimidin-5-yl)oxy)-N-ethyl-5-fluoro-N-isopropylbenzamide	2169923-04-8	/	/
tert-butyl 2,7-diazaspiro[3.5]nonane-7-carboxylate hydrochloride	1023301-84-9	/	/
tert-butyl 4-cyano-4-(tosyloxymethyl)piperidine-1-carboxylate	929302-00-1	/	/
N-ethyl-5-fluoro-N-isopropyl-2-(pyrimidin-5-yloxy)benzamide	2169923-02-6	/	/
N-ethyl-5-fluoro-2-hydroxy-N-isopropylbenzamide	1549490-65-4	/	/
N-ethyl-5-fluoro-N-isopropyl-2-methoxybenzamide	2654082-93-4	/	/

Tell us the step you need covered and the specification you are filing against. We will confirm supply, documentation and lead time.

获取最新活动与法规动态洞察

直接发送到您的邮箱

在此获取行业洞察与 Unibest 动态